Consequently, our core BC predisposition gene set (Table 3) does not include broadly tumor-associated genes such as TP53, PTEN, CDH1, and STK11, which have been implicated across multiple cancer types and are confirmed to contribute to BC predisposition risk [70]. The gene discussed is TP53; the disease is neoplasm.